Search results for: 'Cancer Diagnostics Market'

AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, presenting opportunities for innovation. There has been a...

The concept of companion diagnostics (CDx) was developed when researchers realized that even potent drugs only had an efficacy between 25% and 60%, the lowest being in oncology. Therefore, a clinical pharmacogenetic assay became important to distinguish patients more likely to respond to a drug or at a lesser risk of associated adverse pathophysiol...

Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and translation of blood-based neurology biomarkers, sustai...

19 Jun 2024  |  Global  |  Technology Research

Molecular Diagnostics for Neurodegenerative Diseases: Technology Growth Opportunities, 2024 2028

Leveraging integrated and point-of-care diagnostics with multiomics represents the most promising growth opportunity to advance molecular diagnostics for neurodegenerative diseases

Infographics

×

Neurodegenerative diseases (NDD) pose significant challenges to healthcare systems and affect millions of people worldwide, making early detection crucial. While the current diagnostic strategy is predominantly brain imaging techniques, it is not performed until symptoms are more pronounced. Subtle changes occurring in neural cells during early pro...

20 Jan 2025  |  Global  |  Market Research

Global Cardiac Biomarkers Diagnostics Industry, 2024-2029

Rising Prevalence of CVD and High Sensitivity POCT Driving Transformational Growth in Cardiac Biomarkers Diagnostics

Infographics

×

The global cardiac biomarkers diagnostics market is forecast to record robust growth with the increased prevalence of cardiovascular disease (CVD), multiplex biomarkers, advancements in diagnostic testing technology, higher POCT adoption rates, and an intensive focus on preventive healthcare. CVDs are a leading cause of mortality globally, highligh...

17 Jun 2024  |  Global  |  Market Research

Diagnostics Lab Automation and Monitoring Solutions Growth Opportunities

The Intersection of Automation and Digital Data Exchange Unlocks Value for Diagnostics Labs

Infographics

×

The pathology workforce shortage, accuracy concerns, and uneven distribution of prices and resources are persistent challenges for the diagnostics sector. Lab test results are the foundation of future human health, influencing 70% of clinical decisions. A surge in lab tests yearly volume will result from persistent trends, including aging popu...

Cancer treatment technologies are playing an instrumental role in the effective removal of cancerous tumors through radiation and non-radiation therapies. These therapies offer highly localized, minimally invasive/non-invasive, and personalized treatment options that support effective tumor removal.The growing burden of cancer cases globally—primar...

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical devices, medical imaging, and diagnostics industry. The issue includes advanced medical devices such as drug-eluting biologic envelope, autonomous UV-C disinfection robots, arthroscopic surgical robot, four-dimensi...

At-home diagnostics is a rapidly growing field constantly exploring new and innovative solutions to address the challenges of diagnosing broad-spectrum disorders. Recent advancements in emerging at-home diagnostics technologies have attracted significant interest due to their potential to revolutionize the field. This shift has created promising op...